Thursday, Oct 27th

Last update05:20:13 AM GMT

You are here News Health FDA staff note deaths in Pfizer bone drug study

FDA staff note deaths in Pfizer bone drug study

E-mail Print PDF
A higher percentage of patients treated with an experimental Pfizer Inc drug for osteoporosis died during a clinical trial compared with a placebo, U.S. drug reviewers said in an analysis released on Thursday.

The higher proportion of deaths through five years was statistically significant only for the lowest dose of the drug called Fablyn, said Food and Drug Administration reviewers. More patients given Fablyn, which was co-developed with Ligand Pharmaceuticals Inc, also developed blood clots.


Most Recent Related Stories...

Cuban lung cancer vaccine to be tested in US, NY governor says

Cuban lung cancer vaccineThe Food and Drug Administration (FDA) will allow trials of a Cuban lung cancer vaccine to...

Youth football players show brain changes after just one season

Football brain injuriesWhen it comes to head impact in youth football, it is not just concussion that affects...

'Patient zero' Gaëtan Dugas not source of HIV/Aids outbreak, study confirms

HIV start no longer blamed on patient zeroScientists have managed to reconstruct the route by which HIV/Aids arrived in the US – exonerating...

Americans overwhelmingly support abortion rights

Americans support abortion rightsPolitical candidates, consultants and the media generally misunderstand the politics of abortion rights. They tend to...
America's # 1 Enemy
Tee Shirt
& Help Support!
TVNL Tee Shirt
Conserve our Planet
& Help Support!
Get your 9/11 & Media
Deception Dollars
& Help Support!
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!